ZOLGENSMA is a one-time-only intravenous infusion

Treat patients with systemic corticosteroids (equivalent to oral prednisolone at 1 mg/kg/day) 24 hours before ZOLGENSMA infusion. Continued corticosteroid treatment is required following infusion.1

Clinical signs or symptoms of infection should not be evident at the time of ZOLGENSMA administration.1

ZOLGENSMA is provided as a kit customized to meet the weight-based dosing requirements of each patient.1

ZOLGENSMA is a suspension administered as a single intravenous infusion over 60 minutes.1 Insertion of a backup catheter prior to administration is recommended.

Download the ZOLGENSMA Treatment Guide

Take an in-depth look at the steps to treatment and learn how to store, handle, and infuse ZOLGENSMA.

The recommended dose of ZOLGENSMA is 1.1 × 1014 vector genomes per kilogram (vg/kg) of body weight. Review the ZOLGENSMA Treatment Guide and the Full Prescribing Information for further dosing details.1

ZOLGENSMA Treatment Guide

Download

The recommended dose of ZOLGENSMA is 1.1 × 1014 vector genomes per kilogram (vg/kg) of body weight.
Review the ZOLGENSMA Treatment Guide and the Full Prescribing Information for further dosing details.1

See the preparation, dosing, and infusion process for ZOLGENSMA

Before Treatment

Identifying eligible patients

Before Treatment

After Treatment

Essential post-infusion monitoring and management

After Treatment

Reference: 1. ZOLGENSMA [prescribing information]. Bannockburn, IL: Novartis Gene Therapies, Inc; 2021.